Tag Archives: Transparency Market Research

Growing Trends in Laser Capture Microdissection Market

Human tissues are composed of complex mixtures of different cell types and their biological analysis requires the procurement of pure samples of the cells of interest. Number of approaches have been used in attempts to overcome this difficulty. Laser capture microdissection (LCM) is anautomated sample preparation technology used to isolate and harvest the specific cells of interest from tissue, or organisms by direct microscopic visualization. The technique also called as laser microdissection (LMD), or laser assisted microdissection (LAM or LMD). This technology facilitates the formulation of homogenous isolates of clear cells through which DNA/RNA and various proteins can be achieved for further performingmass spectrophotometry, western blot analyses, polymerase chain reaction (PCR), and quantitative PCR. Certain benefits, such as contamination free and contact free technique, allows more efficient and accurate results, and preservance of cells with an original morphology are expected to provide good growth in the global market. Laser microdissection is now used in a large number of research fields, e.g. cancer research,neurology, forensics or climate research,and plant analysis. The method is for the time being also applied for manipulation of cell cultures or for microengraving of coverslips.A diversity of downstream applications of laser capture microdissection technique are exist includes DNA genotyping and loss-of-heterozygosity (LOH) analysis, RNA transcript profiling, proteomics discovery, cDNA library generation, and signal-pathway profiling.

Read Full Report: http://www.transparencymarketresearch.com/laser-capture-microdissection-market.html

Global laser capture microdissection market is segmented by product type, system type, application, and end users.By product, the global market further segmented intoinstruments, reagents and media, assay kits, consumables, and software and services.The system types segmented into infrared LCM, ultraviolet LCM,immunofluorescence LCM, and ultraviolet and infrared LCM. By considering application, LCM market segmented into diagnostics, research and development, and other applications.Whereas, by end users market might be segmented into academic and government research hospitals, institutes, pharmaceutical companies, CROs and biotechnology companies. Geographically, laser capture microdissection market can be categorized into North America, Latin America, Europe, Asia Pacific, and Middle East and Africa. By product type, instrument segment is expected to account largest share of the global LCM market during forecast period. However, consumables segment observed highest growth rate. Geographically, North America accounted largest share of the market due to availability of skilled personnel to handle LCM technology. However, Asian market is witnessing strongest growth during the forecast period due to expansion of LCM companies and R & D spending. Overall growth of the market is attributed due to strong trend in CROs and pharmaceutical companies. Hence, by end users pharmaceutical companies’ accounted largest share in global laser capture microdissection market 2014.

Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7682

Increasing healthcare expenditure, growing R & D funding, and technical advantages are primary growth drivers of this market. The high-growth potential in emerging markets provide new growth opportunities and technological advancements provide new growth trends to players in the laser capture microdissection market. However,high manufacturing and maintenance cost of equipment and accessories, and lack of skilled personnel are major restraint of the Laser capture microdissection market.

Some of the major players in the laser capture microdissection market include Thermo Fisher Scientific, Inc. (U.S.), Molecular, Machines & Industries (Germany),Danaher Corporation (U.S.), Carl Zeiss AG (Germany), INDIVUMED GmbH (Germany), DeNova Sciences Pte. Ltd. (Singapore), Theranostics Health Inc. (U.S.), Ocimum Biosolutions LLC (U.S.), 3DHISTECH Ltd. (Hungary), and AvanSci Bio LLC (U.S.).

Read More Reports on Medical Devices Market: http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

About us:

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:

Mr. Sudip S

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY – 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Mortuary Equipment Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023

Transparency Market Research announces the release of a new research report titled “Mortuary Equipment Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023”. According to the study, the global mortuary equipment market is estimated to develop at a 6.30% CAGR from 2015 to 2023, growing from a value of US$173.4 mn in 2014 to US$306 mn by 2023.

Browse the full Mortuary Equipment Market (Product Types-Refrigerators & Freezers, Autopsy & Dissection Tables, Cadaver Lifts, Cadaver Trolleys and Others; Applications- Research and Academics, Forensics and Cultural) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2015 – 2023 report at http://www.transparencymarketresearch.com/mortuary-equipment-market.html

On the basis of product type, the mortuary equipment market is segmented into autopsy and dissection tables, cadaver trolleys, refrigerators and freezers, cadaver lifts, and others. Refrigerators and freezers dominate the overall market in terms of revenue owing to increased awareness about the products and high cost of the equipment. Freezers and refrigerators form the most fundamental mortuary equipment needed for storage of corpses and preventing them from decaying. Respective national policies mandating the use of freezers and refrigerators in mortuary facilities has additionally boosted their demand. Moreover, this segment has received tremendous support from the development of advanced mobile equipment.

Cadaver handling and transportation equipment such as lifts and trolleys are anticipated to register the highest growth by 2023 owing to the rise in deaths from unnatural causes. Market players in this segment have been focusing on the development of effective and novel equipment such as portable cadaver scissor lifts with rollers, hand-cranked cadaver lifts, hydraulic autopsy carriers, and hand-cranked autopsy carriers, to ensure increased acceptance of the mortuary products during the forecast period.

Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6973

On the basis of application, the market for mortuary equipment is categorized into forensics, research and academics, and cultural. The increasing use of cadavers in all these application areas has grown in the recent past, boosting the overall mortuary equipment market.

On the basis of geography, the global mortuary equipment market is fragmented into North America, Latin America, Asia Pacific, Europe, and the Middle East and Africa. In terms of revenue, North America dominates the global mortuary equipment market, followed by Europe. These developed regions are mainly driven by the strong presence of leading market players and availability of advanced portable devices with remarkable efficacy. Asia Pacific has been identified as an exceptionally lucrative market for mortuary equipment owing to a favorable gap between demand and supply and rapid development of healthcare infrastructure in the form of hospitals and clinical settings. Given the practice of ensuring proper cleansing and wrapping of the corpses in countries within the Middle East and Africa, the market for mortuary equipment in this region is anticipated to grow over the coming years.

Read Full Press Release: http://www.transparencymarketresearch.com/pressrelease/global-mortuary-equipment-market.htm

Some of the most prominent players operating in the global mortuary equipment market are Thermo Fisher Scientific, Inc., Mortech Manufacturing, Inc., Flexmort, KUGEL Medical Gmbh & o. KG, Ferno-Washington, Inc., LEEC UK, and Mopec.

Mortuary Equipment Market, by Product Type

  • Refrigerators and Freezers
  • Autopsy and Dissection Tables
  • Cadaver Lifts
  • Cadaver Trolleys
  • Others

Mortuary Equipment Market, by Application

  • Research and Academics
  • Forensics
  • Cultural

Mortuary Equipment Market, by Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa (MEA)

About Us:

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact:

Mr.Sudip S

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

Global Report on Teleradiology Market

Teleradiology is the transmission of radiological images from the sender (primary location) to the receiver (secondary acquisition site) via internet technology. This electronic image transfer in a digital format is done for the purpose of consultation or diagnosis, and consistent advancement in the field of digital imaging technology has resulted in the growth of global teleradiology market. Ultrasound, magnetic resonance imaging (MRI), x-ray, computed tomography (CT), and nuclear imaging are some of the major segments of teleradiology.

Double-Digit Growth Forecast for Teleradiology Market

Teleradiology has emerged as the largest as well as the most mature segment of the overall telehealth industry, thanks to evolving technologies in medical imaging. The surging popularity of mhealth all over the world has also catapulted the teleradiology market to greater heights. Apart from this, advanced technologies in the communication sector, rousing acceptance of the Internet, and the vital role of social media platforms has led to the proliferation of the teleradiology market.

Constant upgradation of Radiology Information Systems (RIS) and Picture Archiving and Communication Systems (PACS) is also boosting the process of teleradiology over the past few years, resulting in enhanced image capture, processing, storage, and reporting.

Propelled by these factors, the global market for teleradiology is anticipated to register an impressive CAGR of 22.30% from 2013 to 2019, according to a report by Transparency Market Research. In 2012, the value of the teleradiology market was pegged at US$0.9 bn, which is forecast to grow to US$3.7 bn by 2019.

While the investment opportunities presented by teleradiology are rather strong, this market is anticipated to be challenged by high cost of technology and security concerns with respect to imaging data.

Get Free Sample for Teleradiology Market

Technological Advancements Fueling Developed Teleradiology Markets

The global teleradiology market covers four main regions: Europe, Asia Pacific, North America, and Rest of the World. In 2012, North America emerged as the leader in the teleradiology market with a share of more than 33% in terms of revenue. The key factor driving this regional market is the booming healthcare sector. Presence of well-informed patients, availability of well-equipped healthcare institutions and hospitals, rapid adoption of unique medical approaches, rise in healthcare expenditure, and increased demand for advanced healthcare practices are the leading factors responsible for the growth of the teleradiology market in North America. In addition, the growing use of high-bandwidth internet technologies in medicine and healthcare boosts the teleradiology market in the region.

Western Europe is the second largest teleradiology market, driven by technological advancements and surging healthcare awareness among patients. The Asia Pacific teleradiology market holds immense potential for growth, according to leading market analysts, thanks to ongoing developments in the fields of healthcare informatics and medical imaging.

Radisphere National Radiology Group, Inc., American TeleCare, Inc., Virtual Radiologic (vRad), StatRad, Sectra AB, ONRAD, Inc., Agfa-Gevaert N.V., Cybernet Systems Corporation, and Teleradiology Solutions are some of the most prominent players in the global teleradiology market. Strong competition among these players to obtain a greater share of the market pushes them to develop novel and innovative imaging solutions. This has strongly supported the growth of the teleradiology market.

Browse Full Global Teleradiology Market Research Report With Complete TOC @ http://www.transparencymarketresearch.com/teleradiology-technology-Market.html

Kidney Cancer Drugs Market: High Cost of Drugs to Hamper Market Growth during 2014-2020

Pharmaceuticals_01

Kidneys are among the most crucial organs of the human body. Their role in regulating blood pressure and serving homeostatic functions is critical in maintaining the balance of nutrients and toxins in the body. Kidneys serve as natural blood filters, removing the water-soluble wastes and reabsorbing the essential elements from the blood. Since they play such a crucial role, kidneys require constant regeneration of dead nephrons and proper blood circulation to maintain healthy cell growth, due to which, they are susceptible to metastasis and cancerous tumors. Renal cell carcinoma, the most common type of kidney cancer, is among the toughest cancers to treat, especially in the advanced stages. Until 1980’s, the treatment of kidney cancer included surgical removal of the kidneys. The treatment later progressed to laparoscopic removal of the tumor-affected part of the kidneys, significantly increasing the survival rate and patient comfort. Drugs are usually given to stage four advanced renal cell carcinoma patients with disease progression. Various forms of cancer treatment mechanism have been implemented among the presently approved drugs for kidney cancer; these include, VEGF (Vascular Endothelial Growth Factor) inhibitor, angiogenesis inhibitor, cytokine therapy, and immune modulation therapy to name a few.

Browse Full Report With TOC:- http://www.transparencymarketresearch.com/kidney-cancer-drugs-market.html

This research report provides a detailed analysis of the global kidney cancer drugs market and helps in understanding the various driving factors of this market. The market overview section provides analysis of the market dynamics and trends such as drivers, restraints, and opportunities that influence the current nature of the market. The section also forecasts the future scenario of the market. The executive summary gives detailed insights about the report and the market in general. It also contains a market snapshot, which provides a glimpse into the current scenario of the global kidney cancer drugs market. Event impact analysis and other market dynamics tools such as market attractiveness analysis, regulatory framework analysis, and market share analysis have also been explained in the market overview section of the report, in order to deliver a thorough analysis of the overall competitive scenario in the global kidney cancer drugs market.

The global kidney cancer drugs market is segmented on the basis of major branded drugs produced and geography. By major branded drugs, the market is further segmented into the major brands approved for the indication of renal cell carcinoma such as Afinitor (Everolimus), Avastin (Bevacizumab), Inlyta (Axitinib), Nexavar (Sorafenib), Proleukin (Aldesleukin/Interleukin-2), Sutent (Sunitinib), Torisel (Temsirolimus), and Votrient (Pazopanib). The report also includes pipeline analysis of the most potential drugs, which are currently in phase 2 and phase 3 trials for renal cell carcinoma indication. Considering 2013 as the base year for estimating the market size and 2012 as the historical year, the market size estimations for the period from 2012 to 2020 have been provided for each of the major branded drugs mentioned above in terms of USD million. The CAGR (%) of each market segment for the forecast period between 2012 to 2016 and 2016 to 2020 has also been provided along with market size estimations.

Geographically, the global kidney cancer drugs market has been segmented into four major regions: North America, Europe, Asia Pacific, and Rest of World (RoW), Russia being included in the RoW region. The market size estimations for the period between 2012 and 2020 and market forecast for the period 2014 – 2020 have been provided for each of these regions by revenue in terms of USD million along with the CAGR for the forecast period 2014 to 2020. This study further offers market recommendations for market players of the global kidney cancer drugs market, which include factors that may play a critical role in enhancing or boosting the market share of companies in the near future. The report also advices measures that need to be considered to achieve success for kidney cancer drug manufacturers and marketers globally.

The report concludes with company profiles, which include key information about the major players actively participating in the kidney cancer drugs market. The report profiles the market players in terms of company overview, financial overview, business strategy, recent developments, and product portfolio. The companies featured in this report have exclusive patent rights to the following major branded drugs: Novartis AG., F. Hoffman-La Roche., Pfizer, Inc., Bayer Pharma AG., and GlaxoSmithKline, plc.

The global kidney cancer drugs market is segmented as follows:

Kidney Cancer Drugs Market, by Major Branded Drugs
Sutent (Sunitinib)
Nexavar (Sorafenib)
Afinitor (Everolimus)
Votrient (Pazopanib)
Inlyta (Axitinib)
Avastin (Bevacizumab)
Torisel (Temsirolimus)
Proleukin (Aldesleukin)

Kidney Cancer Drugs Market, by Geography
North America
Europe
Asia Pacific
Rest of the World (RoW)

Get Sample Report:- http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=537

About Us:-
Transparency Market Research (TMR) is a next-generation provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us:-
Mr.Nachiket
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

Nanocapsules Market Segment Forecasts up to 2023

Pharmaceuticals_01

Nanocapsules are drug delivery agents within the size range of 10nm to 1000 nm that are normally composed of a capsule shell and a hollow space in which desired substance or drug molecules are embedded. The ultrafine size of nanocapsules match the biological composition of human body such as RBCs which permits enhanced permeation and retention (EPR) through narrow channels during diffusion. Due to this EPR effect, nanocapsules are used as drug carriers. Nanocapsules can be formulation using various methods such as loading of drug molecules into hollow polyelectrolyte shell and another method being electrostatic layer by layer (LbL) technique. These latest LbL self-assembled polyelectrolyte capsules provide an efficient way to perform multiple drug delivery tasks simultaneously. Some nanocapsules are used for targeted drug delivery in anti-tumor and anti-tuberculosis therapies wherein the outer sphere of nanocapsules is fabricated by the lithography technique. Lipid nanocapsules (DNA LNCs) and multimodular systems (DNA MMS) are used in gene therapy.

Browse Full Report With TOC:- http://www.transparencymarketresearch.com/nanocapsules-market.html

Global investment in nanotechnology research has witnessed a six fold increase during the last decade. Consequently, nanotechnology will completely revolutionize the industrial processes in the near future due to its remarkable economic potential. Some of the key drivers for the market growth include investments and breakthroughs in biomedical, pharmaceutical, electronics, molecular and diagnostic fields. Besides, these nanocapsules are being increasingly used in agrochemicals, environment and wastewater treatments, genetic engineering, consumer goods and cosmetic procedures. Some of the most advanced future applications would be nanocapsule dressings to deliver antibiotics aiding faster wound healing without invasion to the skin. These nanocapsule bandages would be consistently demanded by defence and protection forces as they need not be changed periodically. According to the experts, electronics and magnetic sector will be the largest potential market for nanocapsules, followed by biopharmaceutical industry, catalysis, energy and engineering. However, growth in the nanocapsules market will also pose new challenges with respect to the toxicity and environmental impact of nanocapsules. Recently efforts have been made to overcome these drawbacks by developing eco-friendly versatile nanocapsules. For instance, nanocapsules introduced by the Center for Self-assembly and Complexity, Institute for Basic Science (IBS). Other factors such as cost escalation and consequences on the global economy especially in cases of under-developed economies with poor R&D investment would exhibit low social and ethical acceptance of nanocapsules.

Funding for nanotechnology is soaring worldwide at a competitive level, with each major economic power and many developed economies making a substantial investment to revamp their industrial and postindustrial supply chains. Technological inventions and discoveries in nanotechnology would cause tremendous growth in the global nanocapsule market. Due to a variety of potential applications, nanotechnology is expected to become the key technology in the near future. U.S. has invested around USD 3.7 billion through its National Nanotechnology Initiative for research activities. The European Union had spent approximately USD 1.2 billion and Japan USD 750 million by 2012. Moreover, there is a steady demand for medically advanced procedures in developed as well as developing regions having a well-established healthcare infrastructure. In the Asia Pacific region, the demand for nanocapsules is projected to rise owing to the high disease burden of tuberculosis and cancer. Some of the key factors that are likely to contribute toward the market growth are growing awareness about genetic counselling, genetic disorders, high prevalence of tuberculosis and multi-drug resistant tuberculosis, increasing trend in cancer and tumor ailments and surging demand for oncological treatments.

Presently, nanocapsules are under different stages of clinical trial phases facing several hurdles to gain market entry. However, few commercially available nanocapsules which are now commercially used as several pigments in sunscreen, scratch resistance coatings, catalysts, and biomarkers. Some of the key market players for these commercially available nanocapsules are Abraxis, Artificial Cell Technologies, Inc., BioDelivery Sciences International, Inc., Biophan Technologies, Inc., Cornerstone Pharmaceuticals, Inc., Genetic Immunity, Inc., Keystone Nano, Inc., Makefield Therapeutics, Inc., Nanospectra Biosciences, Inc., and Mersana Therapeutics, Inc.

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. This report provides comprehensive analysis of
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a six-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
It provides distinctive graphics and exemplified SWOT analysis of major market segments

Get Sample Report:- http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5321

About Us:-
Transparency Market Research (TMR) is a next-generation provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us:-
Mr.Nachiket
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com